bioRxivJClub
SHMT1 and SHMT2 inhibition disrupts metabolic adaptation in glioblastoma
bioRxiv · · Preprint · Open access
Schroeder, Harwart + 17 more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Dual inhibition of SHMT1/SHMT2 with (+)-SHIN1 in glioblastoma cells impairs clonogenic growth and invasion and sensitizes cells to death under combined hypoxia and glucose restriction.
- Why it matters: Glioblastoma metabolic reprogramming under hypoxia and nutrient restriction is linked to one-carbon folate metabolism, but how SHMT-dependent flux supports tumour homeostasis and stress tolerance is unclear.
- What they did: The authors treated glioblastoma cell lines and patient-derived glioma stem-like models with (+)-SHIN1, used SHMT2 knockdown in LNT-229, and measured survival, invasion, bioenergetics, redox (NADPH/NADP), metabolomics, 13C6-glucose tracing, and TMT proteomics, with formate supplementation and 3D co-culture expansion assays.
- The result: SHMT2 was enriched in hypoxic and perinecrotic regions and correlated with hypoxia-inducible factor-1 target genes; SHMT inhibition increased respiration under normoxia, reduced lactate and glutathione in G55T2, elevated oxidative stress, and reduced HIF-1-alpha accumulation under combined stress, with formate partially rescuing antitumour effects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.